USO DE IMUNOTERAPIA NA VETERINÁRIA - APLICAÇÕES CLINICAS E PERSPECTIVAS FUTURAS
DOI:
https://doi.org/10.61164/e6vby265Palabras clave:
medicina veterinária; neoplasia; sistema imunológico; terapia inovadora; tratamento alternativoResumen
Esse artigo tem por objetivo levantamento de dados científicos, acerca de uma nova via de tratamento alternativo. Podendo trazer uma nova perspectiva para a veterinária e seus pacientes.
Descargas
Referencias
AKASH, Anant; MISHRA, Mamta; HOQUE, M.; AMARPAL. Advancement in
Cancer Immunotherapy in Veterinary Medicine: A Review. Indian Journal of
Animal Research, v. 55, n. 9, p. 993-998, set. 2021. DOI:
10.18805/ijar.B-4141. Disponível em: https://arccjournals.com/journal/indian-journal-
of-animal-research/B-4141# ruffell 2012. Acesso em: 12 de set. 2025
CORNELL UNIVERSITY COLLEGE OF VETERINARY MEDICINE.
Immunotherapy treatment. Ithaca, NY: Cornell University College of Veterinary
Medicine, [s.d.] Reimpresso de DogWatch (set. 2022). Disponível em:
https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-h
ealth-center/canine-health-information/immunotherapy-treatment. Acesso em: 06 de
set. 2025
EQUIPE CÃES & GATOS. Estudo utiliza imunoterapia para humanos no tratamento
de câncer em cães. Cães & Gatos, 1 jan. 2024. Disponível em:
https://caesegatos.com.br/estudo-utiliza-imunoterapia-para-humanos-no-tratamento-
de-cancer-em-caes//. Acesso em: 12 e set. 2025
PROMEGA. Understanding the Promise of Immunotherapy in Veterinary Medicine.
Promega Connections, 1 out. 2024. Disponível em:
https://www.promegaconnections.com/understanding-the-promise-of-immunot
herapy-in-veterinary-medicine/. Acesso em: 13 de set. 2025
SCHOENFELDER, Allana Talita; BELARMINO, Lucas Airto; BATISTA, Keila Zaniboni
Siqueira. Imunoterapia antitumoral em medicina veterinária: Anti-tumor
immunotherapy in veterinary medicine – REVIEW. Research,
Society and Development, v. 10, n. 4, p. e21810414143, 2021. DOI: 10.33448/rsd-
v10i4.14143. Disponível em:
https://www.researchgate.net/publication/351263626. Acesso em: 12 de set. 2025
TOPALIAN, Suzanne L.; HODI, F. Stephen; BRAHMER, Julie R.; GETTINGER, Scott
N.; SMITH, David C.; McDERMOTT, David F.; POWDERLY, John D.; CARVAJAL,
Richard D.; SOSMAN, Jeffrey A.; ATKINS, Michael B.; LEMING, Philip D.; SPIGEL,
David R.; ANTONIA, Scott J.; HORN, Leora; DRAKE, Charles G.; PARDOLL, Drew
M.; CHEN, Lieping; SHARFMAN, William H.; ANDERS, Robert A.; TAUBE, Janis M.;
McMILLER, Tracee L.; XU, Haiying; KORMAN, Alan J.; JURE-KUNKEL, Maria;
AGRAWAL, Shruti; McDONALD, Daniel; KOLLIA, Georgia D.; GUPTA, Ashok;
WIGGINTON, Jon M.; SZNOL, Mario. Safety, activity, and immune correlates of anti-
PD-1 antibody in cancer. New England Journal of Medicine, v. 366, n. 26, p. 2443-
2454, 28 jun. 2012. DOI: 10.1056/NEJMoa1200690. Disponível em: DOI: https://doi.org/10.1056/NEJMoa1200690
https://www.nejm.org/doi/full/10.1056/NEJMoa1200690. Acesso em: 14 de set. 2025
VETCANCERCARE. Imunoterapia veterinária. VetCancerCare: clínica de oncologia
veterinária, 19 jun. 2024. Disponível em:
https://www.vetcancercare.com.br/imunoterapia-veterinaria/. Acesso em: 28 de set
2025
O’CONNOR, C. M.; LYONS, S. K.; BURKE, B. P.; BARRY, F. P.; MAHON, B. P.
Adoptive T-cell transfer in dogs with lymphoma. Journal of Veterinary Internal
Medicine, v. 26, n. 2, p. 355-362, 2012. Disponível em: DOI: https://doi.org/10.1111/j.1939-1676.2011.00883.x
https://pmc.ncbi.nlm.nih.gov/articles/PMC3278154/. Acesso em: 28 set 2024
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2025 Taina Santana Segovia, Emyle Santos Amaral, Yasmim Santana de Souza, Ana Luiza Barcelos Guimarães, Luiz Eduardo Lira Kuzma , Kayky Rocha Pereira , Geraldo Henrique Kloss de Mello
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Authors who publish in this journal agree to the following terms:
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution License, which permits the sharing of the work with proper acknowledgment of authorship and initial publication in this journal;
Authors are authorized to enter into separate, additional agreements for the non-exclusive distribution of the version of the work published in this journal (e.g., posting in an institutional repository or publishing it as a book chapter), provided that authorship and initial publication in this journal are properly acknowledged, and that the work is adapted to the template of the respective repository;
Authors are permitted and encouraged to post and distribute their work online (e.g., in institutional repositories or on their personal websites) at any point before or during the editorial process, as this may lead to productive exchanges and increase the impact and citation of the published work (see The Effect of Open Access);
Authors are responsible for correctly providing their personal information, including name, keywords, abstracts, and other relevant data, thereby defining how they wish to be cited. The journal’s editorial board is not responsible for any errors or inconsistencies in these records.
PRIVACY POLICY
The names and email addresses provided to this journal will be used exclusively for the purposes of this publication and will not be made available for any other purpose or to third parties.
Note: All content of the work is the sole responsibility of the author and the advisor.
